Season 25 Episode 17
Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lu…
Published on 4 months ago
Season 25 Episode 16
Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.
CME information…
Published on 4 months ago
Season 25 Episode 15
Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.
CME information and select publications here.
Published on 4 months ago
Season 25 Episode 14
Clinical investigators discuss available data guiding the management of hormone receptor-positive metastatic breast cancer.
CME information and select publications here.
Published on 4 months, 1 week ago
Season 25 Episode 13
Dr Adrienne G Waks from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews recent trial updates and their significance for the management of breast cancer.
CME information and select publ…
Published on 4 months, 2 weeks ago
Season 25 Episode 12
Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associat…
Published on 4 months, 4 weeks ago
Season 25 Episode 11
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes data presented at the recent 2024 San Antonio Breast Cancer Symposium applicable to the management of HR-po…
Published on 4 months, 4 weeks ago
Season 25 Episode 10
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME inform…
Published on 5 months ago
Season 25 Episode 9
Dr Kevin S Hughes from the Medical University of South Carolina in Charleston and Dr Mark Robson from Memorial Sloan Kettering Cancer Center in New York discuss current BRCA1/2 genetic testing practi…
Published on 5 months, 2 weeks ago
Season 25 Episode 8
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and s…
Published on 5 months, 3 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate